Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches, ketoprofen gel patches, pantopril sodium enteric-coated tablets, dapagliflozin tablets, and rosuvastatin calcium. It also provides digestive system and metabolic, nervous system, cardiovascular system medications, musculoskeletal, anti-infective, respiratory system medications, blood and hematopoietic system, and reproductive and urinary system and hormone drugs. In addition, the company offers CMO/CDMO; software development and technical; and pharmaceutical retail services. Hunan Jiudian Pharmaceutical Co., Ltd. was founded in 2001 and is based in Changsha, China.
Research context
Hunan Jiudian Pharmaceutical Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Hunan Jiudian Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 52.4% above its 200 day moving average.
From a valuation standpoint, the stock is 26.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.1.
Hunan Jiudian Pharmaceutical Co., Ltd's total revenue sank by 0.4% to $264M since the same quarter in the previous year.
Its net income has increased by 30.0% to $22M since the same quarter in the previous year.
Finally, its free cash flow grew by 38.9% to $46M since the same quarter in the previous year.
Based on the above factors, Hunan Jiudian Pharmaceutical Co., Ltd gets an overall score of 4/5.